Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,234,658
  • Shares Outstanding, K 26,975
  • Annual Sales, $ 2,567 M
  • Annual Income, $ -1,844 M
  • EBIT $ 304 M
  • EBITDA $ 304 M
  • 60-Month Beta 1.18
  • Price/Sales 3.50
  • Price/Cash Flow 29.16
  • Price/Book 1.21

Options Overview Details

View History
  • Implied Volatility 35.34% (+1.82%)
  • Historical Volatility 27.53%
  • IV Percentile 30%
  • IV Rank 21.13%
  • IV High 64.21% on 04/08/25
  • IV Low 27.60% on 08/25/25
  • Expected Move (DTE 9) 3.83 (1.18%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 359
  • Volume Avg (30-Day) 85
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 565
  • Open Int (30-Day) 532
  • Expected Range 321.68 to 329.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.57
  • Number of Estimates 1
  • High Estimate 2.57
  • Low Estimate 2.57
  • Prior Year 2.90
  • Growth Rate Est. (year over year) -11.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
295.01 +10.34%
on 12/19/25
328.25 -0.84%
on 01/06/26
+7.81 (+2.46%)
since 12/05/25
3-Month
292.56 +11.26%
on 10/10/25
343.12 -5.14%
on 10/27/25
+16.33 (+5.28%)
since 10/06/25
52-Week
211.43 +53.95%
on 06/03/25
373.69 -12.90%
on 01/28/25
-17.97 (-5.23%)
since 01/06/25

Most Recent Stories

More News
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz,...

BIO : 325.50 (+0.98%)
Bio-Rad: Q3 Earnings Snapshot

Bio-Rad: Q3 Earnings Snapshot

BIO : 325.50 (+0.98%)
Bio-Rad: Q3 Earnings Snapshot

Bio-Rad: Q3 Earnings Snapshot

BIO : 325.50 (+0.98%)
Bio-Rad Reports Third-Quarter 2025 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30,...

BIO : 325.50 (+0.98%)
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the third quarter of 2025 on Wednesday,...

BIO : 325.50 (+0.98%)
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Alice N. Schwartz, Bio-Rad’s co-founder and Director...

BIO : 325.50 (+0.98%)
Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now?

Bio-Rad Laboratories, Inc. BIO is well-poised to grow in the upcoming quarters, courtesy of its strong traction in the QX600 Droplet Digital PCR (ddPCR) platform. Demand for its quality control and immunology...

MASI : 136.60 (+1.94%)
BIO : 325.50 (+0.98%)
PAHC : 39.54 (+3.05%)
NVST : 23.21 (+2.93%)
Bio-Rad's Management to Participate in Upcoming Investor Conferences

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that members of the company’s executive leadership team will...

BIO : 325.50 (+0.98%)
Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s management will host an informational...

BIO : 325.50 (+0.98%)
Bio-Rad: Q2 Earnings Snapshot

Bio-Rad: Q2 Earnings Snapshot

BIO : 325.50 (+0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and...

See More

Key Turning Points

3rd Resistance Point 337.42
2nd Resistance Point 332.83
1st Resistance Point 329.17
Last Price 325.50
1st Support Level 320.92
2nd Support Level 316.33
3rd Support Level 312.67

See More

52-Week High 373.69
Last Price 325.50
Fibonacci 61.8% 311.71
Fibonacci 50% 292.56
Fibonacci 38.2% 273.41
52-Week Low 211.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar